A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Protein kinases play a pivotal role in cell signaling, and dysregulation of many kinases has been linked to disease development. A large number of kinase inhibitors are therefore currently under investigation in clinical trials, and so far seven inhibitors have been approved as anti-cancer drugs. In...
Asıl Yazarlar: | Fedorov, O, Marsden, B, Pogacic, V, Rellos, P, Müller, S, Bullock, A, Schwaller, J, Sundström, M, Knapp, S |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2007
|
Benzer Materyaller
-
FIKK Kinase, a Ser/Thr Kinase Important to Malaria Parasites, Is Inhibited by Tyrosine Kinase Inhibitors
Yazar:: Benjamin C. Lin, ve diğerleri
Baskı/Yayın Bilgisi: (2017-10-01) -
Insights for the development of specific kinase inhibitors by targeted structural genomics.
Yazar:: Fedorov, O, ve diğerleri
Baskı/Yayın Bilgisi: (2007) -
Natural Compounds and Derivatives as Ser/Thr Protein Kinase Modulators and Inhibitors
Yazar:: Barbara Guerra, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01) -
Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity.
Yazar:: Pogacic, V, ve diğerleri
Baskı/Yayın Bilgisi: (2007) -
Substrate Specificity of Recombinant Ser/Thr Protein Kinase
Yazar:: Anna Zorina, ve diğerleri
Baskı/Yayın Bilgisi: (2015-03-01)